MEPRA
HIKMA
Identification
- Active ingredient (INN)
- MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE
- Internal code
- 13 G 477
- Country of Origin
- Portugal
- Pharmaceutical form
- Powder for Injectable Sol. or IV Perfusion
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/10flacons de 20 ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Children aged 3 months and above are used for the treatment of meningococcal, meningitis or penicillin-sensitive pulmonary pulmonary pulmonary inflammation caused by the sensitive, methicline, sternum, dementia, pulmonary palate, vancomacin, zangari, Ishiria coli, equili, equili, elastic, fragile trachos, acne, acous digestion, abdominal inflammation caused by Ishiria coli, zangalic, fragile tranquilizer, and colonal ingesic.
Associated Conditions
The use of this drug may cause new infections, such as diarrhoea associated with claustridium divcisil or false membrane.
Administration classification, B. Based on the fact that animal reproduction studies have failed to detect a risk to the foetus and there are insufficient studies in pregnant women, or animal studies have shown that there are adverse effects, but sufficient studies in pregnant women have failed to detect a risk to the foetus at any stage of pregnancy, so this drug is safe during pregnancy and can be used after consultation with a doctor.
Mechanism of Action
One antibiotic, linked to the futures that benesilin is associated with bacteria, inhibits the cell wall formation that leads to bacterial cell degradation.
Do you have questions on this? Ask Sina, artificial intelligence to answer all your medical questions.
Write your question here, Sina, prepare the answer for you.